Side-by-side comparison of AI visibility scores, market position, and capabilities
Vancouver-based antibody discovery platform with 104+ partner programs; $75M FY2025 revenue. Expanding into wholly owned assets with ABCL635 in Phase 1 for vasomotor symptoms.
AbCellera Biologics was founded in 2012 in Vancouver, Canada by Carl Hansen, growing out of research at the University of British Columbia. The company built a high-throughput antibody discovery platform integrating microfluidics, genomics, single-cell sequencing, and AI/ML to rapidly identify therapeutic antibody candidates from natural immune responses. AbCellera played a prominent role in the COVID-19 pandemic by discovering bamlanivimab for Eli Lilly in under 90 days.\n\nAbCellera's partnership model operates on a discovery fee plus downstream milestone and royalty structure, having started over 104 partner-initiated programs with downstream participation as of December 2025. Partners include major pharmaceutical companies and biotechs; the company expanded its collaboration with AbbVie in 2025 to develop T-cell engagers for oncology. Total FY2025 revenue was $75 million ($47M from royalties/licensing, $27M from partnered program work), compared to $29 million in 2024—a dramatic increase driven by royalty flows from approved medicines.\n\nIn 2025 AbCellera began transitioning from pure partnership model toward wholly owned therapeutic assets, with ABCL635 (a GnRH receptor antibody for vasomotor symptoms) entering Phase 1. The company maintains approximately $700 million in liquidity, providing a long runway. AbCellera is considered a foundational infrastructure provider for the antibody-based drug discovery ecosystem.
Adobe's generative AI suite with commercially-safe Image Model 5 (4MP photorealism), video editor, and audio tools; integrated partner models like FLUX.2 and GPT Image
Adobe Firefly is Adobe's generative AI platform and suite of creative AI tools, launched in March 2023 as Adobe's flagship response to the generative AI revolution. Firefly was purpose-built to be commercially safe — trained exclusively on Adobe Stock images, openly licensed content, and public domain material rather than scraped web data, addressing a core concern that had made competing generative AI tools risky for professional and enterprise creative use. This positioning allowed Adobe to offer content credentials and indemnification for Firefly outputs, making it the enterprise-safe choice for brands and agencies with legal exposure concerns around AI-generated content.\n\nFirefly's capabilities span multiple creative modalities integrated across Adobe's Creative Cloud suite. Image Model 5 generates photorealistic images at 4 megapixel resolution with precise adherence to reference styles and composition guides. Firefly Video enables AI-powered video editing and generation within Premiere Pro, including object removal, scene extension, and text-to-video features. Firefly Audio tools bring generative AI to sound design and audio editing within Audition. Adobe has also launched a Firefly partner model program that integrates third-party models including FLUX.1 from Black Forest Labs, giving users access to a broader range of generative styles within the familiar Creative Cloud interface.\n\nFirefly is integrated into Photoshop, Illustrator, Express, and Premiere Pro, making it available to Adobe's 30M+ Creative Cloud subscribers without additional purchase. Enterprise licenses include access to custom-trained Firefly models fine-tuned on brand assets, enabling consistent brand identity across AI-generated content. As the market leader in professional creative tools, Adobe's position gives Firefly a distribution advantage that standalone generative AI tools cannot easily replicate.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.